By M&A — Senti Biosciences Adjourns Merger Vote, Seeking Additional Stockholder Support The Clinical Trial Vanguard
Auto-published by the finit.news Events monitor from M&A; summarized by AI and may contain errors — verify against the primary source. October 14, 2026.